Caseware UK (AP4) 2022.0.179 2022.0.179 The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.2022-04-01falseNo description of principal activity22truetrue 05540339 2022-04-01 2023-03-31 05540339 2021-04-01 2022-03-31 05540339 2023-03-31 05540339 2022-03-31 05540339 c:CompanySecretary1 2022-04-01 2023-03-31 05540339 c:Director1 2022-04-01 2023-03-31 05540339 c:Director2 2022-04-01 2023-03-31 05540339 c:RegisteredOffice 2022-04-01 2023-03-31 05540339 d:OfficeEquipment 2022-04-01 2023-03-31 05540339 d:OfficeEquipment 2023-03-31 05540339 d:OfficeEquipment 2022-03-31 05540339 d:OfficeEquipment d:OwnedOrFreeholdAssets 2022-04-01 2023-03-31 05540339 d:CurrentFinancialInstruments 2023-03-31 05540339 d:CurrentFinancialInstruments 2022-03-31 05540339 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 05540339 d:CurrentFinancialInstruments d:WithinOneYear 2022-03-31 05540339 d:ShareCapital 2023-03-31 05540339 d:ShareCapital 2022-03-31 05540339 d:RetainedEarningsAccumulatedLosses 2023-03-31 05540339 d:RetainedEarningsAccumulatedLosses 2022-03-31 05540339 c:OrdinaryShareClass1 2022-04-01 2023-03-31 05540339 c:OrdinaryShareClass1 2023-03-31 05540339 c:OrdinaryShareClass1 2022-03-31 05540339 c:FRS102 2022-04-01 2023-03-31 05540339 c:AuditExempt-NoAccountantsReport 2022-04-01 2023-03-31 05540339 c:AbridgedAccounts 2022-04-01 2023-03-31 05540339 c:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 05540339 2 2022-04-01 2023-03-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 05540339










VASCULAR CONSULTING LIMITED

Unaudited
Financial statements
Information for filing with the registrar
For the year ended 31 March 2023

 
VASCULAR CONSULTING LIMITED
 

Company Information


Directors
Prof. P A Gaines 
Mrs E J Gaines 




Company secretary
Mrs E J Gaines



Registered number
05540339



Registered office
Cannon Hall
Butts Hill

Sheffield

South Yorkshire

S17 4AN





 
VASCULAR CONSULTING LIMITED
Registered number: 05540339

Balance sheet
As at 31 March 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 3 
3,399
2,962

  
3,399
2,962

Current assets
  

Debtors
 4 
15,090
34,607

Cash at bank and in hand
  
1,358,046
1,226,205

  
1,373,136
1,260,812

Creditors: amounts falling due within one year
 5 
(52,375)
(53,900)

Net current assets
  
 
 
1,320,761
 
 
1,206,912

Net assets
  
1,324,160
1,209,874


Capital and reserves
  

Called up share capital 
 6 
100
100

Profit and loss account
  
1,324,060
1,209,774

  
1,324,160
1,209,874


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 15 November 2023.






Prof. P A Gaines
Director

The notes on pages 2 to 5 form part of these financial statements.
Page 1

 
VASCULAR CONSULTING LIMITED
 

 
Notes to the financial statements
For the year ended 31 March 2023

1.


General information

Vascular Consulting Limited is a private company limited by shares incorporated in England within the United Kingdom. The address of the registered office is given in the company information page of these financial statements.
The financial statements are presented in sterling which is the functional currency of the company.
The significant accounting policies applied in the preparation of of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A) of the Companies Act 2006.

 
2.2

Revenue

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates and value added tax.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.5

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.6

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Page 2

 
VASCULAR CONSULTING LIMITED
 

 
Notes to the financial statements
For the year ended 31 March 2023

2.Accounting policies (continued)

 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
25%
Straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.11

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

 
2.12

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 3

 
VASCULAR CONSULTING LIMITED
 

 
Notes to the financial statements
For the year ended 31 March 2023

3.


Tangible fixed assets





Office equipment

£



Cost or valuation


At 1 April 2022
6,492


Additions
1,827



At 31 March 2023

8,319



Depreciation


At 1 April 2022
3,530


Charge for the year on owned assets
1,390



At 31 March 2023

4,920



Net book value



At 31 March 2023
3,399



At 31 March 2022
2,962


4.


Debtors

2023
2022
£
£


Trade debtors
10,870
30,387

Other debtors
4,220
4,220

15,090
34,607



5.


Creditors: Amounts falling due within one year

2023
2022
£
£

Taxation and social security
39,064
43,105

Other creditors
10,241
7,725

Accruals and deferred income
3,070
3,070

52,375
53,900


Page 4

 
VASCULAR CONSULTING LIMITED
 

 
Notes to the financial statements
For the year ended 31 March 2023

6.


Share capital

2023
2022
£
£
Allotted, called up and fully paid



100 (2022 -100) Ordinary shares of £1.00 each
100
100



Page 5